The complex relation between obstructive sleep apnoea syndrome, hypogonadism and testosterone replacement therapy

The complex relation between obstructive sleep apnoea syndrome, hypogonadism and testosterone replacement therapy

Obstructive sleep apnoea syndrome (OSAS) is an under-recognized medical disease. The main risk factors for OSAS are male sex, older age, obesity, and metabolic syndrome, that are also associated with male hypogonadism (MH). Therefore, obesity has been classically identified as the most evident link...

Полное описание

Библиографические подробности
Главные авторы:	Andrea Graziani, Giuseppe Grande, Alberto Ferlin
Формат:	Статья
Язык:	English
Опубликовано:	Frontiers Media S.A. 2023-10-01
Серии:	Frontiers in Reproductive Health
Предметы:	OSAS hypogonadism testosterone testosterone replacement therapy obesity
Online-ссылка:	https://www.frontiersin.org/articles/10.3389/frph.2023.1219239/full

Схожие документы

Management of Male Fertility in Hypogonadal Patients on Testosterone Replacement Therapy
по: Julius Fink, и др.
Опубликовано: (2024-02-01)

Clinical and pharmacological basis of the use of testosterone drugs for hormonal replacement therapy for hypogonadism in men
по: N. I. Volkova, и др.
Опубликовано: (2022-09-01)

Usefulness of routine assessment of free testosterone for the diagnosis of functional male hypogonadism
по: Paolo Facondo, и др.
Опубликовано: (2022-12-01)

ASSESSING CARDIOVASCULAR SAFETY OF TESTOSTERONE REPLACEMENT THERAPY FOR MALE HYPOGONADISM: A SYSTEMATIC REVIEW AND META-ANALYSIS
по: Manarul Iman Alfafa Rachman, и др.
Опубликовано: (2024-09-01)

Impact of testosterone levels and testosterone replacement ther-apy on men’s health
по: Zuzanna Karbowska, и др.
Опубликовано: (2023-12-01)

Acquired Male Hypogonadism in the Post-Genomic Era—A Narrative Review
по: Giuseppe Grande, и др.
Опубликовано: (2023-09-01)

Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men
Опубликовано: (2012-12-01)

Plasma metabolomics in male primary and functional hypogonadism
по: Giuseppe Grande, и др.
Опубликовано: (2023-05-01)

Age-Related Male Hypogonadism and Cognitive Impairment in the Elderly: Focus on the Effects of Testosterone Replacement Therapy on Cognition
по: Giuseppe Lisco, и др.
Опубликовано: (2020-10-01)

LATE ONSET HYPOGONADISM: TO TREAT, NOT TO TREAT AND WHO MUST TREAT?
по: Z. R. Gusova, и др.
Опубликовано: (2016-03-01)

Testosterone replacement therapy and vascular thromboembolic events: a systematic review and meta-analysis
по: Rossella Cannarella, и др.
Опубликовано: (2024-01-01)

Sleep disorders and testosterone deficiency in men
по: I. A. Khripun, и др.
Опубликовано: (2025-01-01)

Evaluation of sexual functional status and consistency of scales in patients with hypogonadotropic hypogonadism before and after testosterone replacement therapy: a single-center experience
по: Umit Aydogan, и др.
Опубликовано: (2023-01-01)

Application of Transdermal Testosterone in Treatment of Male Hypogonadism
по: Mahgol Tajbakhsh, и др.
Опубликовано: (2018-10-01)

The association of hypogonadism with depression and its treatments
по: Rita Indirli, и др.
Опубликовано: (2023-08-01)

Testosterone Replacement Therapy: Effects on Blood Pressure in Hypogonadal Men
по: Geoffrey Hackett, и др.
Опубликовано: (2024-10-01)

Guidelines for the Diagnosis and Treatment of testosterone deficiency (hypogonadism) in male patients with diabetes mellitus
по: Ivan I. Dedov, и др.
Опубликовано: (2017-12-01)

Novel perspectives of testosterone therapy in men with functional hypogonadism: traversing the gaps of knowledge
по: Kristina Groti Antonič, и др.
Опубликовано: (2024-12-01)

The HEAT-Registry (HEmatopoietic Affection by Testosterone): comparison of a transdermal gel vs long-acting intramuscular testosterone undecanoate in hypogonadal men
по: Michael Zitzmann, и др.
Опубликовано: (2022-12-01)

Testosterone replacement therapy in adolescents and young men
по: Alexandra Aponte Varnum, и др.
Опубликовано: (2024-10-01)

Long-term testosterone replacement therapy reduces fatigue in men with hypogonadism
по: Maurício de Almeida Ferreira, и др.
Опубликовано: (2022-02-01)

A National Analysis of Temporal Changes in Prescribing of Testosterone Replacement Therapy Considering Methods of Delivery and Government Regulation
по: Andrew Morton, и др.
Опубликовано: (2021-01-01)

Safety Aspects and Rational Use of Testosterone Undecanoate in the Treatment of Testosterone Deficiency: Clinical Insights
по: Campbell K, и др.
Опубликовано: (2023-03-01)

Syndrome of hypogonadism in males
Опубликовано: (2014-06-01)

Racial differences in hypogonadal improvement and prostate-specific antigen levels in hypogonadal men treated with testosterone replacement therapy
по: Robert M. Coward, и др.
Опубликовано: (2010-12-01)

Testosterone Replacement Therapy in Adolescents With Sickle Cell Disease Reverses Hypogonadism Without Promoting Priapism: A Case Report
по: Belinda F. Morrison, и др.
Опубликовано: (2015-11-01)

Osteoporosis and bone metabolism in patients with Klinefelter syndrome
по: Giuseppe Grande, и др.
Опубликовано: (2023-07-01)

Testosterone and aging male, a perspective from a developing country
по: Bac Nguyen Hoai, и др.
Опубликовано: (2023-12-01)

Testosterone treatment in the aging male: myth or reality?
по: Nicole Nigro, и др.
Опубликовано: (2012-03-01)

Does Testosterone Salvage PDE5i Non-Responders? A Scoping Review
по: Mike Pignanelli, и др.
Опубликовано: (2023-02-01)

Guidelines for the diagnosis and treatment of testosterone deficiency (hypogonadism) in male patients with diabetes mellitus (Draft)
по: Galina Afanas'evna Melnichenko, и др.
Опубликовано: (2017-06-01)

Testosterone replacement therapy and the risk of adverse cardiovascular outcomes and mortality
по: Kevin M. Pantalone, и др.
Опубликовано: (2019-03-01)

Secondary male hypogonadism: A prevalent but overlooked comorbidity of obesity
по: María Molina-Vega, и др.
Опубликовано: (2018-01-01)

The role of anti-aging approaches in managing hypogonadism in sedentary older males
по: Khaled A. Abdel-Sater
Опубликовано: (2024-11-01)

Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men
Опубликовано: (2013-03-01)

High C-reactive protein is associated with increased risk of biochemical hypogonadism: a population-based cohort study
по: Amar Osmancevic, и др.
Опубликовано: (2022-06-01)

Association of hypogonadism with the severity of chronic obstructive pulmonary disease
по: MA. Zohal, и др.
Опубликовано: (2015-12-01)

The clinical and epidemiological characteristics of hypogonadism in men with type 2 diabetes mellitus
по: Galina A. Mel'nichenko, и др.
Опубликовано: (2019-12-01)

The prevalence of hypogonadism in men with type 2 diabetes mellitus in clinical practice
по: Galina A. Melnichenko, и др.
Опубликовано: (2019-06-01)

Clomiphene citrate treatment for late onset hypogonadism: rise and fall
по: Marcelo Marconi, и др.